The warning follows a patient complaint Aug. 14 about black particulate matter found in a vial of semaglutide, according to a Nov. 1 news release from the agency. Subsequent inspections by California regulatory authorities revealed deficiencies at Fullerton Wellness, prompting the facility to voluntarily cease operations Sept. 23.
A follow-up inspection Oct. 17 uncovered practices that could lead to drug contamination, including the use of non-sterile ingredients without proper sterilization.
The agency urged healthcare professionals to check their supplies, quarantine any drugs from Fullerton Wellness and avoid administering them. Patients who have received the compounded drugs were advised to stop using them and consult healthcare providers.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
